Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: a systematic review and meta-analysis von Kim, JH, Han, KH, Park, EY, Kim, ET, Kim, EJ, Tan, DSP, Lee, J-Y, Park, S-Y, Fotopoulou, C, Lim, MC

Volltext

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease von Ledermann, JA, Matias-Guiu, X, Amant, F, Concin, N, Davidson, B, Fotopoulou, C, González-Martin, A, Gourley, C, Leary, A, Lorusso, D, Banerjee, S, Chiva, L, Cibula, D, Colombo, N, Croce, S, Eriksson, AG, Falandry, C, Fischerova, D, Harter, P, Joly, F, Lazaro, C, Lok, C, Mahner, S, Marmé, F, Marth, C, McCluggage, WG, McNeish, IA, Morice, P, Nicum, S, Oaknin, A, Pérez-Fidalgo, JA, Pignata, S, Ramirez, PT, Ray-Coquard, I, Romero, I, Scambia, G, Sehouli, J, Shapira-Frommer, R, Sundar, S, Tan, DSP, Taskiran, C, Van Driel, WJ, Vergote, I, Planchamp, F, Sessa, C, Fagotti, A

Volltext

genomic profile of HER2-amplified breast cancers: the influence of ER status von Marchiò, C, Natrajan, R, Shiu, KK, Lambros, MBK, Rodriguez-Pinilla, SM, Tan, DSP, Lord, CJ, Hungermann, D, Fenwick, K, Tamber, N, Mackay, A, Palacios, J, Sapino, A, Buerger, H, Ashworth, A, Reis-Filho, JS

Volltext

Sixth ovarian cancer consensus conference on clinical research of the gynecologic cancer InterGroup von Vergote, I, Gonzalez-Martin, A, Lorusso, D, Gourley, C, Mirza, MR, Kurtz, J-E, Okamoto, A, Moore, K, Kridelka, F, McNeish, I, Reuss, A, Votan, B, Du Bois, A, Mahner, S, Ray-Coquard, I, Kohn, EC, Berek, JS, Tan, DSP, Colombo, N, Zang, R, Concin, N, O'Donnell, D, Rauh-Hain, A, Herrington, CS, Marth, C, Poveda, A, Fujiwara, K, Stuart, GCE, Oza, AM, Bookman, MA, Participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research

Volltext

ESR1 amplification in endometrial carcinomas: hope or hyperbole? von Tan, DSP, Lambros, MBK, Marchiò, C, Reis-Filho, JS

Volltext

RAD51 expression as a biomarker of homologous recombination deficiency in ovarian cancer von Hoppe, MM, Tan, DSP, Lim, DGZ, Karnezis, A, Huntsman, D, Steel, J, Liu, X, Paul, J, Lewsley, L-A, Siddiqui, N, Brown, R, Jeyasekharan, AD

Volltext

The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast von Tan, D. S. P., Potts, H. W. W., Leong, A. C. K., Gillett, C. E., Skilton, D., Harris, W. H., Liebmann, R. D., Hanby, A. M.

Volltext

The systemic treatment of recurrent ovarian cancer revisited von Baert, T, Ferrero, A, Sehouli, J, O Donnell, DM, González-Martín, A, Joly, F, Van der Velden, J, Blecharz, P, Tan, DSP, Querleu, D, Colombo, N, Du Bois, A, Ledermann, JA

Volltext bestellen

Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast von Leong, Annabelle C.K., Hanby, Andrew M., Potts, Henry W.W., Tan, David S.P., Skilton, Diana, Ryder, Ken, Harris, William H., Liebmann, Rachel D., Barnes, Diana M., Gillett, Cheryl E.

Volltext

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup von Vergote, I, Gonzalez-Martin, A, Lorusso, D, Gourley, C, Mirza, MR, Kurtz, JE, Okamoto, A, Moore, K, Kridelka, F, McNeish, I, Reuss, A, Votan, B, du Bois, A, Mahner, S, Ray-Coquard, I, Kohn, EC, Berek, JS, Tan, DSP, Colombo, N, Zang, R, Concin, N, O'Donnell, D, Rauh-Hain, A, Herrington, CS, Marth, C, Poveda, A, Fujiwara, K, Stuart, GCE, Oza, AM, Bookman, MA, Grimm, C, Berger, R, Chang, TC, Ochiai, K, Gebski, V, Davis, A, Beale, P, Denys, H, Vandecaveye, V, Cancido dos Reis, FJ, Del Pilar Estevez Diz, M, Stuart, G, MacKay, H, Carey, M, Cibula, D, Dundr (path), P, Dorigo, O, Berek, J, Saadeh, A, Boere, I, Lok, C, Coronado, P, Ottevanger, N, Tan, DS, Ng, J, Gonzalez Martin, A, Oaknin, A, Perez Fidalgo, A, Lu, K, López-Zavala, C, Gómez-García, EM, Paoletti, X, Joly, F, Bookman, M, Arend, R, Fujiwara, H, Hasegawa, K, Bruchim, I, Tsoref, D, Oda, K, Enomoto, T, Michel, D, Kim, HS, Lee, JY, Mukhopadhyay, A, Katsaros, D, Pignata, S, Scambia, G, Kohn, E, Lee, JM, Nicum, S, Farrelly, L, Sehouli, J, Keller, M, Braicu, E, Bjørge, L, Auranen, A, Welch, S, Heinzelmann, V, Roxburgh, P, Glasspool, R, Zhu, J

Volltext bestellen

Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor von Subhash, VV, Yeo, MS, Wang, L, Tan, SH, Wong, FY, Thuya, WL, Tan, WL, Peethala, PC, Soe, MY, Tan, DSP, Padmanabhan, N, Baloglu, E, Shacham, S, Tan, P, Koeffler, HP, Yong, WP, Vijayasubhash, Vinod

Volltext bestellen

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease von Colombo, N, Sessa, C, du Bois, A, Ledermann, J, McCluggage, WG, McNeish, I, Morice, P, Pignata, S, Ray-Coquard, I, Vergote, I, Baert, T, Belaroussi, I, Dashora, A, Olbrecht, S, Planchamp, F, Querleu, D, Banerjee, S, Blecharz, P, Bruchim, I, Cibula, D, Concin, N, Davidson, B, Devouassoux-Shisheboran, M, Ferrero, A, Glasspool, R, Gonzalez-Martin, A, Heinzelmann-Schwarz, V, Joly, F, Kim, JW, Kridelka, F, Lorusso, D, Mahner, S, Mikami, M, Mirza, MR, Nicum, S, O'Donnell, DM, Pautier, P, Rodolakis, A, Sehouli, J, Selcukbiricik, F, Singh, N, Tan, DSP, Timmerman, D, Tognon, G, van der Velden, J, Witteveen, PO, Zeimet, AG

Volltext bestellen